Tourmaline Bio Inc. (TRML) — Capital Reinvestment Ratio

Latest as of December 2023: 0.00x

Tourmaline Bio Inc. (TRML) has a Capital Reinvestment Ratio of 0.00x as of December 2023, meaning it reinvests 0% of its operating cash flow ($11.02 Million) in capital expenditures ($2.00). See how leveraged is Tourmaline Bio Inc.'s balance sheet to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.00x

Capex / Operating Cash Flow

Operating Cash Flow

$11.02 Million

USD

Capital Expenditures

$2.00

USD

Data as of

Dec 2023

Most recent filing

Annual Capital Reinvestment Ratio for Tourmaline Bio Inc. (None–None)

Year-by-year Capital Reinvestment Ratio for Tourmaline Bio Inc. from None to None. For live market cap and broader valuation context, see how much is Tourmaline Bio Inc. worth.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow